GLOBUS MEDICAL, INC. (NYSE:GMED) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
things, our sales and operating results for the three month
period ended March 31, 2017. A copy of the press release is
furnished as Exhibit 99.1 to this report.
information included in this Item 2.02, and the exhibits attached
hereto, shall be deemed to be furnished and shall not be deemed
to be filed with the Securities and Exchange Commission for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended.
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated May 3, 2017
|
About GLOBUS MEDICAL, INC. (NYSE:GMED)
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company’s products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company’s portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques. GLOBUS MEDICAL, INC. (NYSE:GMED) Recent Trading Information
GLOBUS MEDICAL, INC. (NYSE:GMED) closed its last trading session down -0.10 at 30.56 with 370,187 shares trading hands.